Zurich Insurance Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-81,355
Closed -$21.7M 360
2026
Q1
$21.7M Buy
+81,355
New +$22M 0.17% 150
2018
Q3
Sell
-43,406
Closed -$6.7M 492
2018
Q2
$6.7M Buy
43,406
+9,685
+29% +$1.46M 0.15% 199
2018
Q1
$4.69M Buy
33,721
+7,126
+27% +$1.05M 0.11% 252
2017
Q4
$3.64M Buy
26,595
+10,106
+61% +$1.34M 0.09% 286
2017
Q3
$2.14M Sell
16,489
-14,828
-47% -$1.98M 0.06% 359
2017
Q2
$4.15M Buy
31,317
+6,893
+28% +$844K 0.12% 214
2017
Q1
$3.01M Buy
24,424
+478
+2% +$56.6K 0.09% 272
2016
Q4
$2.64M Buy
23,946
+7,701
+47% +$855K 0.08% 284
2016
Q3
$1.92M Buy
+16,245
New +$1.91M 0.06% 304

Other funds holding LH

Zurich Insurance Group's LH Position: Q2 2026 in Review

Zurich Insurance Group sold out of Labcorp (LH) in Q2 2026, closing a stake of 81,355 shares — an estimated $21.7M sold.

Zurich Insurance Group first reported a position in LH in Q3 2016 and held it in 9 quarters. The position peaked at $21.7M in Q1 2026. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Zurich Insurance Group reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
  • Zurich Insurance Group sold 81,355 Labcorp shares in Q2 2026, an estimated $21.7M.
  • Zurich Insurance Group first reported a position in Labcorp in Q3 2016 and held it in 9 quarters.
  • Zurich Insurance Group's Labcorp position peaked at $21.7M in Q1 2026.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Zurich Insurance Group's 13F filing for Q2 2026, filed 14 Aug 2026.